FDA Hits Guardian Drug for Lack of Quality Controls, Secure Data Post author:Sam Post published:April 11, 2017 Post category:Drug Industry Daily The FDA cited Guardian Drug Company over quality and data storage issues. Source: Drug Industry Daily You Might Also Like Westminster Recalls Two Thyroid Drugs Due to API Supplier’s Deficiencies August 16, 2018 Novartis’ Pluvicto Racks Up Second Win for PSMA Prostate Cancer December 5, 2022 FDA Calls Out Dutch Manufacturer for Storage Deficiencies September 18, 2018